欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/3767/001
药品名称Mitomycin 40 mg Powder for solution for injection/infusion
活性成分
    • mitomycin 40.0 mg
剂型Powder for solution for infusion/injection
上市许可持有人Accord Healthcare B.V. Winthontlaan 200 3526 KV Utrecht The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Mitomycine Accord 40 mg, poeder voor oplossing voor injectie/infusie
互认成员国 - 产品名称
    • Estonia (EE)
      MITOMYCIN ACCORD
    • Czechia (CZ)
      Mitomycin Accord 40 mg, prášek pro přípravu injekčního/infuzního roztoku
    • Romania (RO)
      Mitomicina 40 mg pulbere pentru solutie injectabila/perfuzabila
    • Slovakia (SK)
      Mitomycin Accord 40 mg prášok na injekčný/infúzny roztok
    • Slovenia (SI)
      Mitomicin Accord 40 mg prašek za raztopino za injiciranje/infundiranje
    • Germany (DE)
      Mitomycin Accord 40 mg Pulver zur Herstellung einer Injektions- bzw. Infusionslösung
    • United Kingdom (Northern Ireland) (XI)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Poland (PL)
      Mitomycin Accord
许可日期2017/07/14
最近更新日期2024/03/20
药物ATC编码
    • L01DC03 mitomycin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase